In Other News

• DPYD Genotyping Assay Supports Safer Fluoropyrimidine Chemotherapy Dosing

• Research Strengthens Bundibugyo Virus Outbreak Readiness with Faster Diagnostics

• New Autoantibody Target Identified in Neuromyelitis Optica Spectrum Disorder

• New Multipurpose Centrifuge Combines High Capacity with Sustainable Cooling

• Blood Biomarker May Track Bone Metastases in Medullary Thyroid Cancer

• Borderline Anemia May Carry Higher Risk Than Current Thresholds Suggest

• New Autoantibody Target Identified in Neuromyelitis Optica Spectrum Disorder

• Blood Biomarkers Help Assess Growth Risks During Steroid Treatment in Duchenne Muscular Dystrophy

• FDA Clearance Expands Digital Pathology Options for Clinical Laboratories

• Biomarker-Guided Framework Aims to Guide Mantle Cell Lymphoma Therapy

• WHO Emergency Listing Supports Rapid Molecular Testing for Ebola Outbreak Response

• FDA Clears Liquid Biopsy Test to Guide Earlier Breast Cancer Therapy Switch

• New Gene-Disease Link May Help Diagnose Rare Neurodevelopmental Disorders

• FDA Clears Liquid Biopsy Test to Guide Earlier Breast Cancer Therapy Switch

• New Blood Biomarker Predicts May Predict Preeclampsia and Fetal Growth Restriction

• Automated System Streamlines DNA Recovery for MRD-Sensitive Testing

• Researchers Identify Shared Molecular Networks Behind Fatigue-Related Illnesses

• New Immune Target Could Support More Precise High Blood Pressure Treatment

• New Immune Target Could Support More Precise High Blood Pressure Treatment

• Researchers Identify Shared Molecular Networks Behind Fatigue-Related Illnesses

• New Liquid Biopsy Platform Uses Red Blood Cells to Detect Hidden Cancer Signals

• Urine Genomic Test Detects More Than Nine in Ten Suspected Bladder Cancers

• Label-Free Imaging Reveals Hidden Immune Activity in Blood Samples